Publications

Detailed Information

Multiplexed Gene Expression and Fusion Transcript Analysis to Detect ALK Fusions in Lung Cancer

Cited 56 time in Web of Science Cited 61 time in Scopus
Authors

Lira, Maruja E.; Kim, Tae Min; Huang, Donghui; Deng, Shibing; Koh, Youngil; Jang, Bogun; Go, Heounjeong; Lee, Se-Hoon; Chung, Doo Hyun; Kim, Woo Ho; Schoenmakers, Eric F. P. M.; Choi, Yoon-La; Park, Keunchil; Ahn, Jin Seok; Sun, Jong-Mu; Ahn, Myung-Ju; Kim, Dong-Wan; Mao, Mao

Issue Date
2013-01
Publisher
American Society for Investigative Pathology
Citation
Journal of Molecular Diagnostics, Vol.15 No.1, pp.51-61
Abstract
Anaplastic lymphoma kinase gene (ALK) fusions have been identified in approximately 5% of non-small-cell lung carcinomas (NSCLCs) and define a distinct subpopulation of patients with lung cancer who are highly responsive to ALK kinase inhibitors, such as crizotinib. Because of this profound therapeutic implication, the latest National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology recommend upfront ALK screening for all patients with NSCLC. The Food and Drug Administration-approved companion diagnostic test (ie, fluorescence in situ hybridization) for identification of ALK-positive patients, however, is complex and has considerable limitations in terms of cost and throughput, making it difficult to screen many patients. To explore alternative screening modalities for detecting ALK fusions, we designed a combination of two transcript-based assays to detect for presence or absence of ALK fusions using NanoString's nCounter technology. By using this combined gene expression and ALK fusion detection strategy, we developed a multiplexed assay with a quantitative scoring modality that is highly sensitive, reproducible, and capable of detecting low-abundant ALK fusion transcripts, even in samples with a low tumor cell content. In 66 archival NSCLC samples, our results were highly concordant to prior results obtained by fluorescence in situ hybridization and IHC. Our assay offers a cost-effective, easy-to-perform, high-throughput, and FFPE-compatible screening alternative for detection of ALK fusions. (J Mol Diagn 2013, 15: 51-61; http://dx.doi.org/10.1016/j.jmoldx.2012.08.006)
ISSN
1525-1578
URI
https://hdl.handle.net/10371/165476
DOI
https://doi.org/10.1016/j.jmoldx.2012.08.006
Files in This Item:
There are no files associated with this item.
Appears in Collections:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share